Sirtex Medical Limited

Sirtex Medical Limited is a global healthcare company specializing in targeted and innovative solutions for liver cancer treatment. The company is known for its SIR-Spheres Y-90 resin microspheres, which are approved for the treatment of unresectable hepatic cancers, including hepatocellular carcinoma (HCC) and metastatic liver tumors from colorectal cancer. Sirtex operates in multiple regions including Asia Pacific, Australia, Europe, the United States, Brazil, and Latin America. The company is dedicated to supporting healthcare professionals and patients with advanced therapeutic products and comprehensive educational resources.